Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company’s product pipeline includes Plozasiran, which has completed Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback